相关实验视频
Updated: Jan 18, 2026

08:48
Author Spotlight: Decoding Mitochondrial Aging
Published on: June 30, 2023
4.8K
在阿尔茨海默病中准线粒体功能障碍:新的发现和观点
1Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Na Bojišti 1, 120 00, Prague 2, Czech Republic.
Progress in neuro-psychopharmacology & biological psychiatry
|September 11, 2025
概括
线粒体功能障碍和能量代谢受损是阿尔茨海默病 (AD) 发展的关键因素. 本综述探讨了遗传学,新陈代谢和病理蛋白之间的联系,突出了潜在的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 线粒体生物学 线粒体生物学
- 病理生理学 病理生理学
背景情况:
- 线粒体能量代谢,动力学和线粒体是阿尔茨海默病 (AD) 病理生理学中至关重要的.
- 遗传因素和线粒体缺陷,特别是在电子运输链中,与粉样β (Aβ) 和病理相关.
- 了解这些分子联系对于AD研究至关重要.
研究的目的:
- 为了审查AD的分子基础.
- 阐明遗传因素,能量代谢和病态蛋白质形成之间的关系.
- 为了突出线粒体功能障碍在AD中的作用.
主要方法:
- 对目前关于阿尔茨海默病的研究进行文献综述.
- 对链接遗传学,线粒体功能和AD病理学的分子机制的分析.
- 综合了关于线粒体动力学,线粒体,神经炎症和亡的发现.
主要成果:
- 改变的线粒体动力学,信号传递,线粒体,神经炎症和亡都与阿尔茨海默病有关.
- 线粒体能量代谢的缺陷,特别是氧化酸化,与Aβ和tau病理有关.
- 遗传倾向加剧了AD中的线粒体功能障碍.
结论:
- 线粒体功能障碍是阿尔茨海默病发病的一个核心因素.
- 线粒体生物标志物和向疗法为AD治疗提供了有前途的途径.
- 对线粒体通路的进一步研究对于开发有效的AD干预措施至关重要.
更多相关视频
相关概念视频
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Electron Transport Chain: Complex I and II
18.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.5K
Mitochondria
19.6K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
19.6K
Alzheimer's Disease: Treatment
827
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
827
Mitochondrial Membranes
16.6K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
16.6K

